Effect of Gender on the Tolerability,Safety and Pharmacokinetics of Clazosentan Following Long-Term Infusion

被引：0
|
作者：
Paul L. M. van Giersbergen
Jasper Dingemanse
机构：
[1] Actelion Pharmaceuticals Ltd,Department of Clinical Pharmacology
[2] Actelion Pharmaceuticals Ltd,undefined
来源：
Clinical Drug Investigation | 2007年 / 27卷
关键词：
Pulmonary Arterial Hypertension; Female Subject; Cerebral Vasospasm; Nasal Congestion; Female Volunteer;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：797 / 832
页数：35
相关论文
共 50 条
  • [1] Effect of gender on the tolerability, safety and pharmacokinetics of clazosentan following long-term infusion
    van Giersbergen, Paul L. M.
    Dingemanse, Jasper
    CLINICAL DRUG INVESTIGATION, 2007, 27 (11) : 797 - 802
  • [2] Long-term safety and tolerability of paroxetine
    Fong, R
    Carpenter, D
    Lipschitz, A
    Krulewicz, S
    Machin, A
    Wilkinson, C
    JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2005, 15 (06) : 856 - 856
  • [3] PHARMACOKINETICS OF TOCAINIDE DURING LONG-TERM INFUSION
    CONINGS, L
    VERBEKE, N
    PHARMACEUTISCH WEEKBLAD-SCIENTIFIC EDITION, 1984, 6 (04) : 167 - 167
  • [4] LONG-TERM SAFETY AND TOLERABILITY OF INTRAVENOUS IMMUNOGLOBULIN
    HANY, M
    RYAN, A
    WEBSTER, ADB
    LANCET, 1991, 338 (8760): : 194 - 195
  • [5] Safety and tolerability of long-term antipsychotic therapy
    不详
    JOURNAL OF CLINICAL PSYCHIATRY, 2003, 64 (11) : 1386 - 1388
  • [6] Safety and tolerability of long-term pramlintide therapy
    Want, LL
    Ratner, RE
    Uwaifo, GI
    DIABETES, 2004, 53 : A150 - A150
  • [7] The long-term safety and tolerability of ispaghula husk
    Oliver, SD
    JOURNAL OF THE ROYAL SOCIETY FOR THE PROMOTION OF HEALTH, 2000, 120 (02): : 107 - 111
  • [8] Safety and tolerability of long-term pramlintide therapy
    Want, LL
    Ratner, RE
    Uwaifo, GI
    DIABETOLOGIA, 2004, 47 : A44 - A44
  • [9] The long-term safety and tolerability of ropinirole in RLS
    Dreykluft, T
    Karrasch, J
    Smuts, J
    Volc, D
    Grunstein, R
    Montplaisir, J
    MOVEMENT DISORDERS, 2004, 19 : S430 - S431
  • [10] Safety, tolerability, and pharmacokinetics of levetiracetam intravenous infusion
    Stockis, A.
    Toublanc, N.
    Ramael, S.
    De Smedt, F.
    Otoul, C.
    Boulanger, P.
    Riethuisen, J.
    EPILEPSIA, 2007, 48 : 107 - 108
12345